For eligible and commercially insured patients,

No matter what your insurance covers, pay as little as $5 or $25 a month*

To do this we need your HIPAA authorization to work on your behalf to help you pay as little as possible.

By taking a little extra time now to provide us with your HIPAA authorization, we can help you pay as little as possible for your Taltz medication. Enrolling in our savings program shouldn’t take more than a few minutes.

If you do not want to provide HIPAA authorization online, please contact Taltz Together at 1-844-TALTZ-NOW (1-844-825-8966) to enroll in our savngs program.

Please see Terms and Conditions below.

Already enrolled in our savings program through your doctor?

Click the button to activate your Taltz Savings Card and complete your enrollment in the savings program. In order to pay as little as possible, we need your HIPAA authorization.

Have concerns about paying for Taltz during this time?

We’re here to help. Contact Taltz Together at 1-844-TALTZ-NOW (1-844-825-8966) for more information on savings and if you have additional questions about Lilly's response to COVID-19, click below.

Follow these 3 steps to save

Taltz savings card request

Enroll in our savings program


share Taltz savings card with your specialty pharmacy

Share your savings number with your specialty pharmacy when they call to set up delivery of your medication

Taltz logo

For ongoing insurance support, call Taltz Together at 1-844-TALTZ-NOW (1-844-825-8966)

If you are commercially insured and your insurance covers Taltz, you will pay as little as $5 a month for up to 36 months. If you are commercially insured and your insurance denies your coverage for Taltz, you will pay as little as $5 or at most around $25 a month for up to 36 months.

Governmental beneficiaries excluded, terms and conditions apply.

*Offer good for up to 36 months from patient qualification into the program or until 12/31/2023, whichever comes first, provided patient continues to meet program terms and conditions. Patients must first use their card by 12/31/2020. Patient must have coverage for Taltz with their commercial drug insurance to pay as little as $5 monthly for a 28-day supply of Taltz, subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate $16,000 maximum annual cap. Patient must have commercial drug insurance and a prescription consistent with FDA approved product labeling to pay as little as $25 monthly for a 28-day supply of Taltz, subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges. Continued participation in the $25 program requires submission of a prior authorization (PA) before the 2nd month fill and, if coverage is denied, an appeal must be submitted prior to 5th month fill. A new PA and appeal or medical exception (ME) must be submitted every 12 months to verify coverage status and potential eligibility for the $5 program. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.

As a reminder, HIPAA is the Health Insurance Portability and Accountability Act that provides data privacy and security to protect your medical information.

TRICARE is a registered trademark of the Department of Defense (DoD), DHA.

Purpose and Safety Summary
PURPOSE AND SAFETY SUMMARY

Important Facts About Taltz® (tȯl-ts). It is a prescription medicine also known as ixekizumab.
Taltz is an injectable medicine used to treat:

  • People six years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
  • Adults with active psoriatic arthritis.
  • Adults with active ankylosing spondylitis.
  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.
It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.

Warnings
  • Taltz affects the immune system. It may increase your risk of infections, which can be serious. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.
  • Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz.
  • If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.
  • Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.
  • Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.
  • You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.
Common side effects
The most common side effects of Taltz include:
  • Injection site reactions
  • Upper respiratory infections
  • Nausea
  • Fungal skin infections
Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using
Before you use Taltz, review these questions with your doctor:
❑ Are you being treated for an infection?
❑ Do you have an infection that does not go away or keeps coming back?
❑ Do you have TB or have you been in close contact with someone with TB?
❑ Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
❑ Do you have Crohn’s disease or ulcerative colitis?
Tell your doctor if:
❑ You need any vaccines or have had one recently.
❑ You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
❑ You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby.
❑ You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.
How to take
See the instructions for use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.
For people under 18 years of age:
  • Weighing less than 50 kg (i.e., 110 lb): Taltz must be given by a healthcare provider.
  • Weighing more than 50 kg (i.e., 110 lb): If your healthcare provider decides that your caregiver may give your injections of Taltz at home, your caregiver should ask and receive training from a healthcare provider on the right way to prepare and inject Taltz.
Learn more
For more information, call 1-800-545-5979 or go to taltz.com.
This summary provides basic information about Taltz and is not comprehensive. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.
Taltz® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries and affiliates.
IX CON BS 29MAY2020